R43/R44 Small Business Innovation Research Grants (SBIR)
NIAID SBIR - Technology Transfer Direct Phase II (SBIR-TT) (R44)
The goal of this Funding Opportunity Announcement (FOA) is to move commercially-viable diagnostic inventions from NIAID and NIDDK intramural research laboratories into the marketplace. This FOA solicits Small Business Innovation Research (SBIR) grant applications from Small Business Concerns (SBCs) for projects that further develop and commercialize such inventions. The Direct-to-Phase II grant mechanism is intended to facilitate SBIR-type R&D, to expand R&D opportunities for applicant SBCs, and to enhance the pace of technology development and commercialization.
|Notice(s) for this Opportunity|
|Letter of Intent Due Date|
|Application Due Date|
November 14, 2014, by 5:00 PM local time of applicant organization. All types of non- AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.